Brekhman, I. I., and I. V. Dardymov. “New substances of plant origin which increase nonspecific resistance.” Annual review of pharmacology 9.1 (1969): 419-430.
Brown, R. P., P. L. Gerbarg, and Z. Ramazanov. “Rhodiola rosea; a phytomedicinal overview. HerbalGram 56: 40–52.” (2002).
Bystritsky, Alexander, Lauren Kerwin, and Jamie D. Feusner. “A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD).” The Journal of Alternative and Complementary Medicine 14.2 (2008): 175-180.
Darbinyan, V., et al. “Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.” Phytomedicine 7.5 (2000): 365-371.
Darbinyan, V., et al. “Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.” Nordic journal of psychiatry 61.5 (2007): 343-348.
Dharmananda, Subhuti. “Tibetan herbal medicine.” INTERNATIONAL JOURNAL OF ORIENTAL MEDICINE 26.1 (2001): 1-13.
Heinrich, Michael, et al. Fundamentals of pharmacognosy and phytotherapy. Elsevier Health Sciences, 2012.
Kessler, Ronald C., et al. “The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).” Jama 289.23 (2003): 3095-3105.
Khanum, Farhath, Amarinder Singh Bawa, and Brahm Singh. “Rhodiola rosea: a versatile adaptogen.” Comprehensive reviews in food science and food safety 4.3 (2005): 55-62.
Kirsch, Irving, et al. “Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.” PLoS Med 5.2 (2008): e45.
Mao, Jun J., et al. “Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.” Phytomedicine 22.3 (2015): 394-399.
McGovern, E., and T. J. McDonnell. “Herbal medicine–sets the heart racing!.” Irish medical journal (2010).
Mell, C. D. “Dyes, tannins, perfumes, and medicines from Rhodiola rosea.” Textile Colorist 60.715 (1938): 483-4.
Olsson, Erik MG, Bo von Schéele, and Alexander G. Panossian. “A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.” Planta medica 75.02 (2009): 105-112.
Panossian, A., G. Wikman, and J. Sarris. “Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.” Phytomedicine 17.7 (2010): 481-493.
Panossian, Alexander, and Georg Wikman. “Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.” Current clinical pharmacology 4.3 (2009): 198-219.
Saratikov, A. S. “Golden root (Rhodiola rosea).” Russia: Tomsk (1974).
Schutgens, F. W. G., et al. “The influence of adaptogens on ultraweak biophoton emission: a pilot‐experiment.” Phytotherapy Research 23.8 (2009): 1103-1108.
Shevtsov, V. A., et al. “A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work.” Phytomedicine 10.2 (2003): 95-105.
Spasov, A. A., et al. “A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.” Phytomedicine 7.2 (2000): 85-89.
Van Diermen, Daphné, et al. “Monoamine oxidase inhibition by Rhodiola rosea L. roots.” Journal of ethnopharmacology 122.2 (2009): 397-401.
Xia, Nan, et al. “Schisandra chinensis and Rhodiola rosea exert an anti-stress effect on the HPA axis and reduce hypothalamic c-Fos expression in rats subjected to repeated stress.” Experimental and therapeutic medicine 11.1 (2016): 353-359.